Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #2,251 to #2,300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Alkyl and aryl transferases → Category:EC 2.5
  2. Nitrogenous group transferases → Category:EC 2.6
  3. Carbon-carbon double bond isomerases → Category:EC 5.3.3
  4. Sulfur-sulfur bond isomerases → Category:EC 5.3.4
  5. Phosphotransferases (phosphomutases) → Category:EC 5.4.2
  6. Amide synthases → Category:EC 6.3.1
  7. Carbon-nitrogen ligases with glutamine as amide-n-donor → Category:EC 6.3.5
  8. AMI:Fixing the GAP-Quality Improvement Program for AMI Shown to be Effective → Special:Badtitle/NS100:AMI:Fixing the GAP-Quality Improvement Program for AMI Shown to be Effective
  9. A large study demonstrates no gender differences in short- and long-term outcomes following PCI → Special:Badtitle/NS100:A large study demonstrates no gender differences in short- and long-term outcomes following PCI
  10. A meta-analysis of over 180,000 patients suggests that drug eluting stents are safe for both on-label and off-label use → Special:Badtitle/NS100:A meta-analysis of over 180,000 patients suggests that drug eluting stents are safe for both on-label and off-label use
  11. Abciximab in addition to a high loading dose of clopidogrel does not improve outcomes in STEMI patients: Results from the BRAVE-3 Trial → Special:Badtitle/NS100:Abciximab in addition to a high loading dose of clopidogrel does not improve outcomes in STEMI patients: Results from the BRAVE-3 Trial
  12. Abnormal pressure gradient distal to the implanted bare metal stent is associated with the occurrence of in-stent restenosis → Special:Badtitle/NS100:Abnormal pressure gradient distal to the implanted bare metal stent is associated with the occurrence of in-stent restenosis
  13. Absorbable drug eluting stents are safe up to one year in single de novo coronary artery lesions → Special:Badtitle/NS100:Absorbable drug eluting stents are safe up to one year in single de novo coronary artery lesions
  14. Acoustic Cardiography: New Technique for Resynchronization Device Optimization May Provide Improved Outcomes → Special:Badtitle/NS100:Acoustic Cardiography: New Technique for Resynchronization Device Optimization May Provide Improved Outcomes
  15. Acute Myocardial Infarction with Hyperoxemic Therapy II (AMIHOT II) in ST Elevation MI with Rebuttal by Dr. Stone → Special:Badtitle/NS100:Acute Myocardial Infarction with Hyperoxemic Therapy II (AMIHOT II) in ST Elevation MI with Rebuttal by Dr. Stone
  16. Acute ischemic stroke: a decade of education and clinical investigation isn’t enough → Special:Badtitle/NS100:Acute ischemic stroke: a decade of education and clinical investigation isn’t enough
  17. Adjusting Clopidogrel loading dose according to platelet reactivity monitoring is associated with a decreased rate of stent thrombosis and no increase in bleeding → Special:Badtitle/NS100:Adjusting Clopidogrel loading dose according to platelet reactivity monitoring is associated with a decreased rate of stent thrombosis and no increase in bleeding
  18. Almost two years after implantation, Sirilimus-eluting coronary stents remain exposed to the circulation. August 11, 2007 → Special:Badtitle/NS100:Almost two years after implantation, Sirilimus-eluting coronary stents remain exposed to the circulation
  19. Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI → Special:Badtitle/NS100:Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI
  20. Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD → Special:Badtitle/NS100:Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD
  21. Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007 → Special:Badtitle/NS100:Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007
  22. Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance → Special:Badtitle/NS100:Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance
  23. Anxious individuals are at risk for heart attacks → Special:Badtitle/NS100:Anxious individuals are at risk for heart attacks
  24. Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial → Special:Badtitle/NS100:Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial
  25. Arginine metabolite found to predict mortality in patients with cardiogenic shock → Special:Badtitle/NS100:Arginine metabolite found to predict mortality in patients with cardiogenic shock
  26. Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT → Special:Badtitle/NS100:Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT
  27. Atherosclerosis: Study links atherosclerosis progression to traffic exposure → Special:Badtitle/NS100:Atherosclerosis: Study links atherosclerosis progression to traffic exposure
  28. Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study → Special:Badtitle/NS100:Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study
  29. Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial → Special:Badtitle/NS100:Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial
  30. BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine → Special:Badtitle/NS100:BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine
  31. Better to be a pear than an apple: new prospective look at associations between fat distribution and coronary heart disease → Special:Badtitle/NS100:Better to be a pear than an apple: new prospective look at associations between fat distribution and coronary heart disease
  32. Biolimus Eluting Stents Shown to be as Safe and Effective as Sirolimus Eluting Stents in Everyday Clinical Practice: Results from the LEADERS Trial → Special:Badtitle/NS100:Biolimus Eluting Stents Shown to be as Safe and Effective as Sirolimus Eluting Stents in Everyday Clinical Practice: Results from the LEADERS Trial
  33. Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trial → Special:Badtitle/NS100:Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trial
  34. Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trial → Special:Badtitle/NS100:Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trial
  35. Cardiac Resynchronization Therapy and Single Center Experience Links Survival → Special:Badtitle/NS100:Cardiac Resynchronization Therapy and Single Center Experience Links Survival
  36. Cardiac arrest during weekends and nights is associated with poor outcomes → Special:Badtitle/NS100:Cardiac arrest during weekends and nights is associated with poor outcomes
  37. Cardiogenic Shock: New Treatment Options with Percutaneous Left Ventricular Assist Devices? → Special:Badtitle/NS100:Cardiogenic Shock: New Treatment Options with Percutaneous Left Ventricular Assist Devices?
  38. Cardiologists’ Use of Pulmonary Artery Catheter Information in CCU Treatment Decisions → Special:Badtitle/NS100:Cardiologists’ Use of Pulmonary Artery Catheter Information in CCU Treatment Decisions
  39. Cardiovascular risk increases with incremental doses of celecoxib → Special:Badtitle/NS100:Cardiovascular risk increases with incremental doses of celecoxib
  40. Changes in Residents’ Hours of Work Not Generally Reflected in Improved Outcomes → Special:Badtitle/NS100:Changes in Residents’ Hours of Work Not Generally Reflected in Improved Outcomes
  41. Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research → Special:Badtitle/NS100:Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research
  42. Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation → Special:Badtitle/NS100:Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation
  43. Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes → Special:Badtitle/NS100:Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes
  44. CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents → Special:Badtitle/NS100:CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents
  45. Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction → Special:Badtitle/NS100:Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction
  46. Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease → Special:Badtitle/NS100:Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease
  47. Coronary heart disease mortality in young women makes the headline news → Special:Badtitle/NS100:Coronary heart disease mortality in young women makes the headline news
  48. Culotte is better than crush for bifurcation lesions: Results from the Nordic Stent Technique study → Special:Badtitle/NS100:Culotte is better than crush for bifurcation lesions: Results from the Nordic Stent Technique study
  49. Cyclosporine Reduces Reperfusion Injury and Infarct Size Following Acute Myocardial Infarction → Special:Badtitle/NS100:Cyclosporine Reduces Reperfusion Injury and Infarct Size Following Acute Myocardial Infarction
  50. Darapladib A Direct Lipoprotein Associated Phospholipase A2 Inhibitor Reduces Necrotic Core but not Plaque Deformability → Special:Badtitle/NS100:Darapladib A Direct Lipoprotein Associated Phospholipase A2 Inhibitor Reduces Necrotic Core but not Plaque Deformability

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"